Stock of the Day

Myovant Sciences (MYOV)

$26.98

$0.00 (0.0%)

Market Cap: $2.62B

About Myovant Sciences

Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids.

The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.